Price $10.18 |
Market Cap
2.1B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.55
|
P/S
0.86
|
Dividend %
-
|
|
P/CF
44.8
|
P/FCF
20.8
|
Op. Cash Flow
262.2K
|
FCF
0.4
|
|
Op. Margin
-7.20%
|
Net Margin
-10.80%
|
ROE
-19.60%
|
ROI
-4.00%
|
|
ROA
-5.10%
|
EPS Growth
-13.50%
|
Current Ratio
1.0
|
Debt/Equity
137.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Oncolytics Biotech, Inc. (USA) (ONCY) | $2.55 | - | - | 49.2M | Strong Buy |
| RTI Surgical Inc (RTIX) | $4.38 | - | - | 289.6M | Strong Buy |
| Altimmune Inc (ALT) | $3.20 | - | - | 16.5M | Strong Buy |
| Sangamo Therapeutics Inc (SGMO) | $11.21 | - | - | 1.42B | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.73 | - | - | 146.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
